"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 2 | 2 | 4 |
| 1998 | 7 | 4 | 11 |
| 1999 | 10 | 0 | 10 |
| 2000 | 15 | 2 | 17 |
| 2001 | 4 | 8 | 12 |
| 2002 | 11 | 4 | 15 |
| 2003 | 15 | 6 | 21 |
| 2004 | 16 | 4 | 20 |
| 2005 | 12 | 1 | 13 |
| 2006 | 4 | 2 | 6 |
| 2007 | 19 | 5 | 24 |
| 2008 | 38 | 2 | 40 |
| 2009 | 22 | 8 | 30 |
| 2010 | 25 | 6 | 31 |
| 2011 | 38 | 7 | 45 |
| 2012 | 43 | 6 | 49 |
| 2013 | 32 | 6 | 38 |
| 2014 | 34 | 9 | 43 |
| 2015 | 52 | 9 | 61 |
| 2016 | 50 | 7 | 57 |
| 2017 | 51 | 9 | 60 |
| 2018 | 41 | 9 | 50 |
| 2019 | 43 | 7 | 50 |
| 2020 | 44 | 10 | 54 |
| 2021 | 50 | 3 | 53 |
| 2022 | 50 | 0 | 50 |
| 2023 | 49 | 0 | 49 |
| 2024 | 42 | 5 | 47 |
| 2025 | 38 | 1 | 39 |
| 2026 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Novel risk score for predicting acute cardiovascular and cerebrovascular events after chest radiotherapy in patients with breast or lung cancer. Eur J Prev Cardiol. 2026 Mar 13; 33(4):513-525.
-
Phase 1 Trial of Withania somnifera Leaf Extract (RH324) in Advanced Non-Small Cell Lung Cancer Including [18F]FDG PET/CT as a Short-Term Metabolic Biomarker to Assess Efficacy: A Novel Model for Assessment of Complimentary Therapies in Early Phase Human Clinical Trials. Integr Cancer Ther. 2026 Jan-Dec; 25:15347354251410182.
-
Pre-diagnostic body mass index trajectories and associations with lung cancer risk. Am J Epidemiol. 2026 Feb 05; 195(2):358-366.
-
Spatial Profiling Reveals Distinct Molecular and Immune Evolution of Mouse Lung Adenocarcinoma Precancers with or Without Carcinogen Exposure. Adv Sci (Weinh). 2026 Mar; 13(17):e12597.
-
EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge. Nat Commun. 2026 Jan 14; 17(1):1726.
-
Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact. J Thorac Oncol. 2026 Jan; 21(1):41-76.
-
Characterization of a bronchoscopically induced transgenic lung cancer pig model for human translatability. Lab Anim (NY). 2026 01; 55(1):12-20.
-
Identification of immunogenic KIF5B-RET fusion neopeptides driving immune stimulation in tumor specific CD8+ T cells. Front Immunol. 2025; 16:1635810.
-
Revisiting LLMs and Lung Cancer Questions: How AI Responds to Common Lung Cancer Questions Two Years Later. Acad Radiol. 2025 Dec; 32(12):7581-7588.
-
Single site metastatic rhabdomyosarcoma: An INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) pooled analysis. Eur J Cancer. 2025 Oct 16; 229:115793.